CME GROUP INC. (CME)

Current Report Filed: 2026-04-27

Key Insights

CME amended its 364-day multi-currency credit facility to $7 billion (expandable to $10 billion) with Bank of America and Citibank, maintaining financial flexibility for clearing house operations and managing potential liquidity events from clearing firm failures or market disruptions.
The facility is specifically designed for temporary liquidity support in unlikely but critical scenarios such as clearing firm defaults, depositary failures, or domestic payment system disruptions, indicating CME's proactive risk management for its clearing operations.
The amendment maintains the consolidated tangible net worth covenant requirement, ensuring CME operates under appropriate financial discipline while preserving access to substantial backup liquidity resources for protecting market integrity.

Quarterly Report Filed: 2026-04-24

Key Insights

CME maintains a diversified revenue base across clearing and transaction fees, market data, and other revenue streams, with detailed segment breakdowns showing exposure to interest rates, equities, foreign exchange, and commodities markets.
The company has an active debt management strategy with multiple bond issuances maturing between 2025-2048, including recent notes at varying coupon rates (2.65% to 5.30%), indicating refinancing activity and capital structure optimization.
Outstanding common and preferred stock classes remain stable with consistent share counts across quarters, suggesting no significant dilution or major capital restructuring during Q1 2026.
Multi-class stock structure (Class A and Class B common stock) with preferred stock outstanding indicates a complex governance framework, typical for established financial exchanges with different voting rights across shareholder classes.

Current Report Filed: 2026-04-22

Key Insights

CME Group filed Q1 2026 earnings results on April 22, 2026, disclosing financial performance for the quarter ended March 31, 2026 through a press release (Exhibit 99.1), which is standard quarterly earnings reporting.
The filing includes non-GAAP financial measures (revenues, expenses, operating income, net income, and EPS) alongside GAAP results, with management reconciliations provided to show adjusted performance metrics that exclude certain items.
The 8-K was signed by Lynne Fitzpatrick, Senior Managing Director, President and CFO, confirming executive continuity in financial leadership with no management changes indicated.

Insider Trading Filed: 2026-03-30

Key Insights

The reporting person, William R. Shepard, acquired a significant amount of CME Group Inc. (CME) common stock through a dividend reinvestment plan, increasing their beneficial ownership.
The transactions appear to be routine and in line with the reporting person's ongoing investment in the company.
There are no major changes or noteworthy events reported in this Form 4 filing.

Insider Trading Filed: 2026-03-19

Key Insights

Jonathan L. Marcus, Sr. MD General Counsel of CME Group Inc., sold 3,291 shares of the company's Class A common stock at an average price of $333.37 per share on March 17, 2026.
The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2025, indicating a pre-planned insider transaction.
Following the reported transaction, Marcus now directly owns 7,192 shares of CME Group's Class A common stock.

Insider Trading Filed: 2026-03-17

Key Insights

Lynne Fitzpatrick, the President and CFO of CME Group, has acquired 5,504 shares of the company's common stock through the vesting of performance shares granted in 2022. This indicates management's confidence in the company's long-term performance.
Fitzpatrick has also surrendered 2,515 shares to cover tax withholding obligations related to the vesting of the performance shares and restricted stock. This suggests the executive is not cashing out a significant portion of her holdings.
The reported transactions represent a net increase of 2,989 shares in Fitzpatrick's direct beneficial ownership of CME Group's common stock, which now stands at 23,913 shares.

Insider Trading Filed: 2026-03-17

Key Insights

The reporting person, Timothy Francis McCourt, is the Sr. MD Global Head of Equity & FX at CME Group Inc. (CME), indicating that he holds a senior leadership position within the company.
McCourt acquired 5,504 shares of CME Group's Class A common stock through the vesting of performance shares granted in 2022, suggesting he is being compensated through equity-based awards.
McCourt surrendered 2,810 shares to fulfill tax withholding obligations related to the performance share award and an additional 94 shares to fulfill tax withholding obligations upon the vesting of restricted stock, indicating he is proactively managing his equity position.

Insider Trading Filed: 2026-03-17

Key Insights

Jonathan L. Marcus, the Senior Managing Director and General Counsel of CME Group Inc., acquired 5,270 shares of the company's common stock through a performance share award vesting.
To fulfill tax withholding obligations, Marcus surrendered 2,377 and 261 shares, reducing his direct beneficial ownership to 10,483 shares.
The transaction suggests continued confidence by a key executive in the company's long-term performance, as indicated by the vesting of performance-based equity awards.

Insider Trading Filed: 2026-03-17

Key Insights

Hilda Harris Piell, Sr MD & Chief HR Officer of CME Group, acquired 7,076 shares of CME common stock through a vesting of performance shares granted in 2022. This indicates the company's commitment to incentivizing and retaining key executives.
Piell also disposed of 3,039 shares to fulfill tax withholding obligations related to the performance share award, suggesting she plans to hold a substantial portion of the shares received.
The performance share award was based on CME's total shareholder return relative to the S&P 500 over a three-year period, aligning executive compensation with long-term shareholder value creation.

Insider Trading Filed: 2026-03-17

Key Insights

Suzanne Sprague, the COO and Global Head of Clearing at CME Group, exercised 5,504 performance shares that vested on March 15, 2026, indicating the company's strong performance and her commitment to the organization.
Sprague surrendered 2,515 shares (2,439 to fulfill tax withholding obligations and 76 for restricted stock vesting) suggesting she maintains a significant direct ownership position in CME Group.
The reported transactions suggest continued insider confidence in CME Group's business and prospects, as the COO exercises performance shares and retains a meaningful equity stake in the company.

Insider Trading Filed: 2026-03-17

Key Insights

Terrence A. Duffy, the Chairman and CEO of CME Group Inc., acquired 62,902 shares of Class A common stock through a performance share award vesting, indicating his continued commitment to the company.
Duffy also surrendered 27,866 shares to fulfill tax withholding obligations related to the performance share award, which suggests he is managing his equity position responsibly.
The reported transactions provide insight into the company's executive compensation and equity incentive programs, which may be of interest to investors evaluating CME Group's management and corporate governance practices.

Insider Trading Filed: 2026-03-17

Key Insights

Ken Vroman, the Chief Transformation Officer, acquired 7,076 shares of CME Group Inc. (CME) in a performance share award, indicating the company's confidence in his leadership and ability to drive transformation.
Vroman surrendered 3,135 shares to fulfill tax withholding obligations, suggesting a potential cash flow impact but maintaining a significant direct ownership stake of 18,851 shares.
The vesting of performance shares is tied to the company's total shareholder return relative to the S&P 500 over a three-year period, aligning Vroman's compensation with long-term shareholder value creation.

Insider Trading Filed: 2026-03-17

Key Insights

Julie Winkler, the Senior Managing Director and Chief Commercial Officer, exercised 8,256 performance shares that vested based on the company's total shareholder return relative to the S&P 500 over a 3-year period.
Winkler surrendered 3,658 shares to the company to fulfill tax withholding obligations, indicating a partial divestment of her position.
The transaction suggests Winkler maintains significant direct ownership of 30,110 CME Group shares, aligning her interests with those of shareholders.

Insider Trading Filed: 2026-03-17

Key Insights

Derek Sammann, a senior managing director at CME Group, acquired 8,256 shares of CME Group Class A common stock through a performance share award under the company's Omnibus Stock Plan.
Sammann disposed of 3,627 shares to cover tax withholding obligations related to the performance share award, indicating he retained a significant portion of the shares.
Sammann also holds additional indirect beneficial ownership of 11,028 shares in a trust and 7,022 shares through his spouse, suggesting he has a substantial investment in CME Group.

Insider Trading Filed: 2026-03-17

Key Insights

CME Group's Chief Accounting Officer, Jack J. Tobin, acquired 608 shares of common stock through a performance share award vesting, indicating the company's continued commitment to incentivizing key executives.
Tobin also disposed of 179 shares to fulfill tax withholding obligations, suggesting he remains bullish on the company's long-term prospects.
The vesting of performance shares based on the company's total shareholder return relative to the S&P 500 over a three-year period suggests strong financial and operational performance by CME Group.

Insider Trading Filed: 2026-03-17

Key Insights

The reporting person, Sunil Kiran Cutinho, the Chief Information Officer of CME Group Inc., acquired 8,256 shares of the company's common stock through a vesting of performance shares granted in 2022.
Cutinho also disposed of 3,658 shares to fulfill tax withholding obligations related to the receipt of the performance share award, resulting in a net increase of 4,598 shares in his direct ownership of CME Group stock.
This transaction suggests the reporting person's continued confidence in CME Group's performance and aligns his interests with those of the company's shareholders.

Insider Trading Filed: 2026-03-12

Key Insights

The reporting person, Jack J. Tobin, who is the MD Chief Accounting Officer, has disposed of 105 shares of CME Group Inc. common stock.
This transaction represents a small reduction in Tobin's direct ownership of CME stock, which now stands at 24,980 shares.
The transaction was a routine disposal of shares, likely for personal reasons, and does not indicate any significant change in Tobin's position or outlook on the company.

Insider Trading Filed: 2026-03-12

Key Insights

Ken Vroman, the Chief Transformation Officer of CME Group, sold 5,160 shares of Class A common stock on March 12, 2026 at an average price of $309.
This sale represents a decrease in Vroman's direct ownership of CME Group shares from 20,070 to 14,910 shares.
Insider selling, even by high-level executives, can signal potential concerns about the company's future performance or valuation.

Insider Trading Filed: 2026-03-09

Key Insights

Elizabeth A. Cook, a director of CME Group Inc., sold 1,000 shares of the company's common stock at $320 per share.
This sale represents a small portion of Cook's total beneficial ownership of 17,771 shares, which are held indirectly through a trust.
Insider selling can sometimes signal reduced confidence in the company's outlook, though a single transaction may not be indicative of a broader trend.

Annual Report Filed: 2026-02-26

Key Insights

CME Group's revenue streams, including clearing and transaction fees, market data, and other revenue, have remained relatively stable over the past three fiscal years.
The company's clearing and transaction fees, which account for the majority of revenue, have seen a slight year-over-year increase in the 2025 fiscal year compared to the prior two years.
CME Group's market data and information services revenue have shown steady growth, indicating the company's ability to generate recurring revenue streams beyond its core clearing and transaction business.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information